The pharmaceutical landscape has transformed dramatically over the past decade. Traditional blockbuster drugs have given way to precision medicine, focusing on targeted therapeutics for rare and orphan indications. This paradigm shift is reshaping clinical research and commercialization strategies. In his latest article, Drew McCormick dives into how manufacturers can optimize commercial strategies to maximize the success of new products and, most importantly, enhance patient outcomes. Learn more: https://lnkd.in/gUSgKxBm
EVERSANA’s Post
More Relevant Posts
-
Orion, a globally operating pharmaceutical company, is revolutionizing the research and development of innovative medicines with the help of large language models (LLMs) like GPT-4. Together, we developed a tailored ChatGPT-like tool designed to meet the unique challenges of pharmaceutical research. This powerful tool can summarize extensive research documents, respond to inquiries, and provide accurate, cited answers — accelerating the drug development process and enhancing efficiency for their researchers and medical affairs team. Read the whole case to learn more about how Orion is supercharging their R&D efforts with AI 👇
Orion – Supporting innovative medicine with GenAI
reaktor.com
-
Technology is playing a huge role in bridging the knowledge gap and ensuring that HCPs, pharma and patients are all aligned. To help save as many lives as possible, M3 is passionate about achieving effective medical communication and increased knowledge sharing. Read the article in full from Fierce Pharma. #pharma #pharmaceutical #HCPs #medical #doctors https://lnkd.in/ek4XGnWN
The Power of 3 - How M3 Unifies Global Comms, Business Intelligence Research and Global Research
fiercepharma.com
-
Posters to help you explore therapeutic oligonucleotides and unlock the future of medicine -- Read the #analyteguru blog.
Unlocking the Future of Medicine: Exploring Therapeutic Oligonucleotides
thermofisher.com
-
Prof. of Surgery, Dept. of Surgery UTHCT,Tyler,TX Director,Trauma Wound Care, UT Health East ,Tyler,TX
Dear Colleagues, Our recent publication in the American Journal of Case Reports by authors from the University of Texas Health Science Center, Tyler, Texas, USA, sheds light on the use of reinforced tissue matrices in complex cases of penetrating abdominal trauma. The study showcases two cases where OviTex reinforced tissue matrices were employed to achieve and maintain abdominal wall closure, resulting in favorable outcomes. This research highlights the potential of reinforced biologics as an alternative to biological meshes in contaminated surgical fields. Furthermore, the study suggests that OviTex reinforced tissue matrices may offer a cost-effective option for achieving abdominal wall closure, even in complex cases. The complete report is now available on the American Journal of Case Reports webpage. #medicalcommunity #abdominaltrauma #surgicalprocedures #biologics #research. PUBLICATION LINK: https://lnkd.in/gPCKER5P
Definitive Closure Using an Ovine Reinforced Tissue Matrix in Contaminated Penetrating Abdominal Trauma
amjcaserep.com
-
Is Structure Therapeutics, the Up Start GLP-1 Receptor Developer A Target--Their Phase 2 Data Looks Promising https://lnkd.in/eYp985v5
TrialSiteNews | Independent Censorship-Free Media for Health & Biomedical Research
trialsitenews.com
-
🌬️ Navigating pharmacokinetics is essential in medical treatment, yet it can be complex. 📚 Simplifying the vital concepts of agonism, antagonism, partial agonism, and reverse agonism is our mission. 🪁 Imagine this: the wind as the drug and the kite as the biological effect! 🪁 Let us demystify these principles for you. #Pharmacokinetics #MedicalScience #SimplifiedLearning #BiologicalEffects #UnderstandingMedicine #Medicine #MedicalEducation
-
-
Oligonucleotides and Innovation in Drug Development These short DNA/RNA strands are revolutionizing personalized medicine, offering precise disease-targeting at the source. Learn more in our White Paper https://lnkd.in/erny9J3G #DrugDiscovery #PersonalizedMedicine #Oligonucleotides #HealthcareInnovation #DrugDevelopment
Get a free white paper
alliancepharmaco.com
-
Scilligence offers a central, unified repository for storing diverse data generated during lipid nanoparticle (LNP) research, including nanoparticle design, characterization data, assay results, and pre-clinical data. Our centralized storage eases data accessibility, avoids risk of data-loss, and reduces human errors, ensuring both quality control and compliance, while providing a seamless transfer of pre-clinical R&D to formulation operations. Watch the video below to learn more about how to manage your LNP workflows end-to-end in one unified platform. https://hubs.la/Q02vbz4S0
Informatics Workshop 2024: Scilligence Unified Platform for LNP Based Therapeutics
https://www.youtube.com/
-
Explore therapeutic oligonucleotides and unlock the future of medicine -- Read the #analyteguru blog.
Unlocking the Future of Medicine: Exploring Therapeutic Oligonucleotides
thermofisher.com
-
In the fourth edition of our neurosciences blog series, Parexel expert and former regulator, Simona Stankeviciute, M.D., shares valuable insights on several best practices and creative approaches to assist biotech companies in developing effective trial design strategies and planning for successful regulatory submissions. Read the full article here: https://lnkd.in/e5EF48ex #Alzheimers #Regulatory #ParexelBiotech
